Cesarean section and primary pulmonary hypertension: the role of intravenous dexmedetomidine

International Journal of Obstetric Anesthesia

Volumn 18, Issue 3, 2009, Pages 262-267

  Toyama, H ^a   Wagatsuma, T ^a   Ejima, Y ^a   Matsubara, M ^a   Kurosawa, S ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain natriuretic peptide; Cesarean section; Dexmedetomidine; General anesthesia; Primary pulmonary hypertension

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DEXMEDETOMIDINE; DOBUTAMINE; FENTANYL; GLYCERYL TRINITRATE; MIDAZOLAM; NITRIC OXIDE; PROPOFOL; PROSTACYCLIN; VECURONIUM;

ADULT; ANESTHESIA LEVEL; ANESTHETIC RECOVERY; ARTICLE; CASE REPORT; CESAREAN SECTION; CONTINUOUS INFUSION; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG INTERMITTENT THERAPY; FEMALE; GENERAL ANESTHESIA; HEART FAILURE; HEMODYNAMIC PARAMETERS; HUMAN; LUNG ARTERY PRESSURE; OBSTETRIC ANESTHESIA; PAIN; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; SEDATION; SYSTOLIC BLOOD PRESSURE; UTERINE TUBE LIGATION;

ADRENERGIC ALPHA-AGONISTS; ADULT; ANESTHESIA, OBSTETRICAL; CESAREAN SECTION; DEXMEDETOMIDINE; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; NATRIURETIC PEPTIDE, BRAIN; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; TREATMENT OUTCOME;

EID: 67649509821     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijoa.2008.08.001     Document Type: Article

References (32)

1. Rubin L.J. Primary pulmonary hypertension. N Engl J Med 336 (1997) 111-117
2. D'Alonzo G.E., Barst R.J., Ayres S.M., et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 115 (1991) 343-349
3. McCaffrey R.N., and Dunn L.H. Primary pulmonary hypertension in pregnancy. Obstet Gynecol Surv 19 (1964) 567-591
4. Weiss B.M., Zemp L., Seifert B., et al. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 31 (1998) 1650-1657
5. Elkayam U., and Gleicher N. Cardiac Problems in Pregnancy. 3rd edition (1998), Wiley-Liss, New York, NY 183-90
6. Aantaa R., and Jalonen J. Perioperative use of alpha2-adrenoceptor agonists and the cardiac patient. Eur J Anaesthesiol 23 (2006) 361-372
7. Mukoyama M., Nakao K., Hosoda K., et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87 (1991) 1402-1412
8. Leuchte H.H., Holzapfel M., Baumgartner R.A., et al. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. J Am Coll Cardiol 43 (2004) 764-770
9. Nagaya N., Nishikimi T., Uematsu M., et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 102 (2000) 865-870
10. Wiedemann R., Ghofrani H.A., Weissmann N., et al. Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: response to iloprost inhalation. J Am Coll Cardiol 38 (2001) 1130-1136
11. Leuchte H.H., Holzapfel M., Baumgartner R.A., Neurohr C., Vogeser M., and Behr J. Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension. Chest 128 (2005) 2368-2374
12. Power K., and Avery A. Extradural analgesia in the intrapartum management of a patient with pulmonary hypertension. Br J Anaesth 63 (1989) 116-120
13. Johnsson M.D., and Saltzman D.H. Cardiac disease. In: Datta S. (Ed). Anesthetic and Obstetric Management of High-Risk Pregnancy (1991), Mosby-Year Book, Inc., St. Louis 245-251
14. Khan M.J., Bhatt S.B., and Kryc J.J. Anesthetic considerations for parturients with primary pulmonary hypertension: review of the literature and clinical presentation. Int J Obstet Anesth 5 (1996) 36-42
15. Sitbon O., Humbert M., Jagot J.L., et al. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. Eur Respir J 12 (1998) 265-270
16. But A.K., Ozgul U., Erdil F., et al. The effects of pre-operative dexmedetomidine infusion on hemodynamics in patients with pulmonary hypertension undergoing mitral valve replacement surgery. Acta Anaesthesiol Scand 50 (2006) 1207-1212
17. Kutter A.P., Kastner S.B., Bettschart-Wolfensberger R., and Huhtinen M. Cardiopulmonary effects of dexmedetomidine in goats and sheep anaesthetised with sevoflurane. Vet Rec 159 (2006) 624-629
18. Kastner S.B., Kull S., Kutter A.P., Boller J., Bettschart-Wolfensberger R., and Huhtinen M.K. Cardiopulmonary effects of dexmedetomidine in sevoflurane-anesthetized sheep with and without nitric oxide inhalation. Am J Vet Res 66 (2005) 1496-1502
19. Ebert T.J., Hall J.E., Barney J.A., Uhrich T.D., and Colinco M.D. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 93 (2000) 382-394
20. Hodgkinson R., Husain F.J., and Hayashi R.H. Systemic and pulmonary blood pressure during caesarean section in parturients with gestational hypertension. Can Anaesth Soc J 27 (1980) 389-394
21. Guler G., Akin Z., Tosun E., Eskitascoglu E., Mizrak A., and Boyaci A. Single-dose dexmedetomidine attenuates airway and circulatory reflexes during extubation. Acta Anaesthesiol Scand 49 (2005) 1088-1091
22. Sia A.T., Kwek K., and Yeo G.S. The in vitro effects of clonidine and dexmedetomidine on human myometrium. Int J Obstet Anesth 14 (2005) 104-107
23. Ala-Kokko T.I., Pienimäki P., Lampela E., Hollmén A.I., Pelkonen O., and Vähäkangas K. Transfer of clonidine and dexmedetomidine across the isolated perfused human placenta. Acta Anaesthesiol Scand 41 (1997) 313-319
24. Van de Velde M., Teunkens A., Kuypers M., Dewinter T., and Vandermeersch E. General anaesthesia with target controlled infusion of propofol for planned caesarean section: maternal and neonatal effects of a remifentanil-based technique. Int J Obstet Anesth 13 (2004) 153-158
25. Wadsworth R., Greer R., MacDonald J.M., and Vohra A. The use of remifentanil during general anaesthesia for caesarean delivery in two patients with severe heart dysfunction. Int J Obstet Anesth 11 (2002) 38-43
26. Orme R.M., Grange C.S., Ainsworth Q.P., and Grebenik C.R. General anaesthesia using remifentanil for caesarean section in parturients with critical aortic stenosis: a series of four cases. Int J Obstet Anesth 13 (2004) 183-187
27. Macfarlane A.J., Moise S., and Smith D. Caesarean section using total intravenous anaesthesia in a patient with Ebstein's anomaly complicated by supraventricular tachycardia. Int J Obstet Anesth 16 (2007) 155-159
28. Draisci G., Valente A., Suppa E., et al. Remifentanil for cesarean section under general anesthesia: effects on maternal stress hormone secretion and neonatal well-being: a randomized trial. Int J Obstet Anesth 17 (2008) 130-136
29. Resnik J.L., Hong C., Resnik R., et al. Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. Am J Obstet Gynecol 193 (2005) 450-454
30. Nanno H., Sagawa N., Itoh H., et al. Nitric oxide metabolite concentrations in maternal plasma decrease during parturition: possible transient down-regulation of nitric oxide synthesis. Mol Hum Reprod 4 (1998) 609-616
31. Yoshimura T., Yoshimura M., Yasue H., et al. Plasma concentration of atrial natriuretic peptide and brain natriuretic peptide during normal human pregnancy and the postpartum period. J Endocrinol 140 (1994) 393-397
32. National Institutes of Health (NIH) Consensus Development Panel. Effect of corticosteroids for fetal maturation on perinatal outcomes. Am J Obstet Gynecol 173 (1995) 246-252